Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 216
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Crowdcuring the Blues: People, Technology and Research Against Depression

Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

How does Sprint Training Impact Blood Sugar and Inflammation?

Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...

Nepalese shrines and parks: hotspots for pathogen exchange between primates and humans?

In Nepal people and primates come into close contact where humans both intentionally and unintentionally...

Backer Badge Funded